Guardian Pharmacy Services, Inc.
GRDN
$34.91
-$0.74-2.08%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.46% | 113.11% | 8.73% | -4.42% | -20.89% |
| Total Depreciation and Amortization | 4.09% | -1.66% | 6.36% | 4.21% | 2.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.18% | -7.34% | 6.53% | 28.01% | -27.66% |
| Change in Net Operating Assets | -844.72% | -65.31% | 1,658.27% | 76.36% | -63.77% |
| Cash from Operations | -82.48% | 22.83% | 41.30% | 13.60% | -21.43% |
| Capital Expenditure | -18.74% | 18.82% | -20.92% | 25.82% | -28.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 87.63% | 55.15% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -95.04% | 9.01% | -14.62% | 104.72% |
| Cash from Investing | -0.85% | 47.47% | 31.05% | -134.52% | 16.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.48% | 32.47% | -41.08% | -1.06% | 97.51% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -377.41% | 309.88% | 108.35% | 36.77% | 51.33% |
| Cash from Financing | -168.87% | 50.55% | 27.48% | 20.71% | 94.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.49% | 64.87% | 266.75% | -48.41% | 128.68% |